Vázquez M - Search Results

1

MDR-1 and MRP2 Gene Polymorphisms in Mexican Epileptic Pediatric Patients with Complex Partial Seizures.

Escalante-Santiago D, Feria-Romero IA, Ribas-Aparicio RM, Rayo-Mares D, Fagiolino P, Vázquez M, Escamilla-Núñez C, Grijalva-Otero I, López-García MA, Orozco-Suárez S. Escalante-Santiago D, et al. Among authors: vazquez m. Front Neurol. 2014 Oct 9;5:184. doi: 10.3389/fneur.2014.00184. eCollection 2014. Front Neurol. 2014. PMID: 25346718 Free PMC article.

2

Average parameters as a trend to reduce the residual variability in bioequivalence trials.

Fagiolino P, Vazquez M. Fagiolino P, et al. Among authors: vazquez m. Eur J Drug Metab Pharmacokinet. 1998 Apr-Jun;23(2):153-9. doi: 10.1007/BF03189332. Eur J Drug Metab Pharmacokinet. 1998. PMID: 9725474

3

Average parameters in bioavailability studies: an application to slow-release amitriptyline formulation.

Fagiolino P, Vázquez M, Savio E, Domínguez L, Aiache JM, Beyssac E. Fagiolino P, et al. Among authors: vazquez m. Eur J Drug Metab Pharmacokinet. 1998 Apr-Jun;23(2):160-5. doi: 10.1007/BF03189333. Eur J Drug Metab Pharmacokinet. 1998. PMID: 9725475 Clinical Trial.

4

In vitro approach to study the influence of the cardiac output distribution on drug concentration.

Fagiolino P, Wilson F, Samaniego E, Vázquez M. Fagiolino P, et al. Among authors: vazquez m. Eur J Drug Metab Pharmacokinet. 2003 Apr-Jun;28(2):147-53. doi: 10.1007/BF03190504. Eur J Drug Metab Pharmacokinet. 2003. PMID: 12877574

5

The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.

Fagiolino P, Eiraldi R, Vázquez M. Fagiolino P, et al. Among authors: vazquez m. Clin Pharmacokinet. 2006;45(5):433-48. doi: 10.2165/00003088-200645050-00001. Clin Pharmacokinet. 2006. PMID: 16640451 Review.

6

Influence of efflux transporters on drug metabolism: theoretical approach for bioavailability and clearance prediction.

Fagiolino P, Vázquez M, Eiraldi R, Maldonado C, Scaramelli A. Fagiolino P, et al. Among authors: vazquez m. Clin Pharmacokinet. 2011 Feb;50(2):75-80. doi: 10.2165/11539230-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21241069 Review.

7

Clearance and bioavailability study through arterio-venous drug concentrations relationship.

Fagiolino P, Vázquez M, Eiraldi R. Fagiolino P, et al. Among authors: vazquez m. Eur J Pharm Sci. 2013 Mar 12;48(4-5):825-9. doi: 10.1016/j.ejps.2013.01.016. Epub 2013 Feb 9. Eur J Pharm Sci. 2013. PMID: 23402973

8

Concentration-dependent mechanisms of adverse drug reactions in epilepsy.

Vázquez M, Fagiolino P, Mariño EL. Vázquez M, et al. Curr Pharm Des. 2013;19(38):6802-8. doi: 10.2174/1381612811319380012. Curr Pharm Des. 2013. PMID: 23530511

9

Usefulness of salivary drug monitoring for detecting efflux transporter overexpression.

Fagiolino P, Vázquez M, Maldonado C, Ruiz ME, Volonté MG, Orozco-Suárez S, Lazarowski A. Fagiolino P, et al. Among authors: vazquez m. Curr Pharm Des. 2013;19(38):6701-8. doi: 10.2174/13816128113199990368. Curr Pharm Des. 2013. PMID: 23530513 Clinical Trial.

10

Sex related differences on valproic acid pharmacokinetics after oral single dose.

Ibarra M, Vázquez M, Fagiolino P, Derendorf H. Ibarra M, et al. Among authors: vazquez m. J Pharmacokinet Pharmacodyn. 2013 Aug;40(4):479-86. doi: 10.1007/s10928-013-9323-3. Epub 2013 Jun 20. J Pharmacokinet Pharmacodyn. 2013. PMID: 23784346 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,157 results

Search Page

Filters